🇺🇸 FDA
Patent

US 6143290

Tumor regression by adenovirus expression of wild-type p53

expired A61KA61K38/00A61K38/1709

Quick answer

US patent 6143290 (Tumor regression by adenovirus expression of wild-type p53) held by The Board of Regents of the University of Texas System expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
94
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P